Ligand validation:3OPH

MA4: CYCLOHEXYL-HEXYL-BETA-D-MALTOSIDE

MA4 is a Ligand Of Interest in 3OPH designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3OPH_MA4_A_294	33%	69%	0.104	0.904	0.3	0.86	-	-	0	0	31%	0.3143
3OPH_MA4_A_1	8%	65%	0.228	0.693	0.5	0.83	-	-	1	0	100%	1
1N9B_MA4_A_300	97%	57%	0.062	0.979	0.68	0.97	-	4	0	0	100%	0.8491
4FH4_MA4_A_301	95%	46%	0.069	0.973	0.88	1.19	2	4	0	0	100%	1
4FCF_MA4_A_301	95%	58%	0.066	0.969	0.55	1.06	-	3	1	0	100%	1
2ZD8_MA4_A_301	91%	41%	0.08	0.967	0.8	1.47	1	7	0	0	100%	1
1ONG_MA4_A_300	91%	53%	0.079	0.964	0.78	1.02	1	3	1	0	100%	0.824
5EE8_MA4_A_302	88%	62%	0.073	0.948	0.53	0.93	-	2	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.